Olopatadine Hydrochloride
💊 Brand Formulations & Prices
65 brands sorted by unit price
Contova
Contova
Olonex
Alleloc
Conrif
Olopta
Optadin
Olodin
Olorid
Alercon
Contova
Aladay
Alchek
Allet
Lopadine
Olarif
Ologen
Olopan
Opatin
Patadin
Alacot
Olofix
Patalon
Olosol
Conrif DS
Contova DS
Olodin DS
Olon-DS
Olopta DS
Olpadin
Optadin-DS
Alercon DS
Olarif DS
Olopan DS
Olacing DS
Opatin DS
OPD DS
Alacot DS
Alleloc DS
Lopadine DS
Patalon DS
Aladay DS
Alchek DS
Allet DS
Olofix DS
Ologen DS
Olosol DS
Olpadin DS
Patadin DS
Lopadine Max
Patalon Max
Alacot Max
Aladay Max
Allet Max
Olacing Max
Ologen Max
Olopan Pro
Opatin Max
OPT
Olpadin 7
Patadin Max
Lopadine
Olopan
Opatin
Olpadin 7 SUD
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesAlacot DS eye drops
is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis
... Read more
Alacot DS eye drops
is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.
Alacot DS Nasal Spray
is indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.
Alacot DS tablet
is indicated in the treatment of allergic rhinitis (swelling of the nasal membranes caused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.
It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.
Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.
Patients should be advised not to wear a contact lens if their eye is red. Alacot DS ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction.
Before initial use, Alacot DS Nasal Spray by releasing 5 sprays or until a fine mist appears. When Alacot DS Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Alacot DS Nasal Spray into the eyes. Patients should be informed to avoid spraying Alacot DS Nasal Spray in their eyes.
Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.
Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.
Mode of Action
: Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.
Pharmacokinetics
: Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion